Atlas Trials

Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

Clinical trial NCT06425133 · RECRUITING

Trial details

NCT number
NCT06425133
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2024-07-19
Primary completion
2027-09-01
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.